Year of investment
PolyPhotonix is a bio-photonic R&D company that has designed, developed and manufactured a non-invasive photonic based medical device for the prevention and treatment of diabetic retinopathy, the leading cause of preventable blindness among working-age individuals in the western world.
CPI value creation
Throughout its development and growth, PolyPhotonix has utilised CPI facilities to support the integration of electronics into their photonics-based medical device, adding functionality and scalability whilst helping to reduce costs. Along with the electrical integration support, CPI assisted in the initial design process to meet the needs of the end-user, enabling minimal disruption to the usual sleep patterns of patients.